ResMed | RMD - Trade Debtors


ResMed reported $1.04B in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Ansell USD 231.1M 15.4M Dec/2025
Artivion USD 103.68M 6.31M Dec/2025
AtriCure USD 79.98M 8.67M Jun/2026
Baxter International USD 1.86B 158M Jun/2026
Cochlear AUD 568.4M 17.5M Dec/2025
Cooper Companies USD 788.9M 20.3M Jun/2026
CSL USD 4.32B 1.35B Dec/2025
Dexcom USD 1.27B 175.4M Jun/2026
Edwards Lifesciences USD 973M 60.9M Mar/2026
Fisher Paykel Healthcare NZD 347.5M 11.8M Jun/2026
Globus Medical USD 739.28M 3.84M Jun/2026
Haemonetics USD 216.07M 784K Jun/2026
Idexx Laboratories USD 627.08M 70.13M Jun/2026
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 588.7M 44M Jun/2026
Integra LifeSciences USD 267.19M 2.78M Jun/2026
Intuitive Surgical USD 1.67B 77.6M Jun/2026
Medtronic USD 6.36B 286M Jun/2026
Philips EUR 3.6B 70M Jun/2026
Ramsay Health Care AUD 2.48B 22.3M Dec/2025
ResMed USD 1.04B 37.4M Jun/2026
Sigma Healthcare AUD 2.56B 2.23B Dec/2025
Sonic Healthcare AUD 1.39B 23.76M Dec/2024
Steris USD 1.01B 79.6M Jun/2026
Teleflex USD 364.61M 917K Jun/2026
Thermo Fisher Scientific USD 9.45B 247M Jun/2026